Lessee, Operating Lease, Liability, to be Paid, Year Three of Nurix Therapeutics, Inc. from 30 Nov 2021 to 30 Nov 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Nurix Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 30 Nov 2021 to 30 Nov 2024.
  • Nurix Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Nov 2024 was $2,992,000, a 2.7% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $2,992,000 +$79,000 +2.7% 30 Nov 2024 10-K 28 Jan 2025 2024 FY
Q4 2023 $2,913,000 -$1,417,000 -33% 30 Nov 2023 10-K 15 Feb 2024 2023 FY
Q4 2022 $4,330,000 -$730,000 -14% 30 Nov 2022 10-K 09 Feb 2023 2022 FY
Q3 2022 $4,330,000 31 Aug 2022 10-Q 06 Oct 2022 2022 Q3
Q2 2022 $4,330,000 31 May 2022 10-Q 07 Jul 2022 2022 Q2
Q1 2022 $1,738,000 28 Feb 2022 10-Q 08 Apr 2022 2022 Q1
Q4 2021 $5,060,000 30 Nov 2021 10-K 28 Jan 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.